Search

Your search keyword '"Hoffmann, Inga"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Hoffmann, Inga" Remove constraint Author: "Hoffmann, Inga"
38 results on '"Hoffmann, Inga"'

Search Results

1. AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication

2. Self-reported exhaustion and a 4-item physical frailty index to predict the incidence of major complications after onco-geriatric surgery

3. High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma

6. LRP1B—a prognostic marker in tubo-ovarian high-grade serous carcinoma

7. Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer

8. Self-reported Exhaustion and a 4-item Physical Frailty Index to Predict the Incidence of Major Complications after Onco-Geriatric Surgery

9. DNA methylation-based classification of sinonasal tumors

10. Abstract P2-03-23: Retrospective evaluation of outcomes in a real-world, prospective cohort using EndoPredict: Results from the Charité registry

11. Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue

12. Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer

13. Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma

14. Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis

15. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location‐dependent patterns of genetic and epigenetic alterations

17. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location‐dependent patterns of genetic and epigenetic alterations.

18. The Clinically Used Iron Chelator Deferasirox is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases

19. The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases

21. 4‐Biphenylalanine‐ and 3‐Phenyltyrosine‐Derived Hydroxamic Acids as Inhibitors of the JumonjiC‐Domain‐Containing Histone Demethylase KDM4A

22. Substituted 2-(2-Aminopyrimidin-4-Yl)Pyridine-4-Carboxylates as Potent Inhibitors of Jumonjic Domain-Containing Histone Demethylases

24. Discovery of Novel Fatty Acid Dioxygenases and Cytochromes P450 : Mechanisms of Oxylipin Biosynthesis in Pathogenic Fungi

36. DNA methylation-based classification of sinonasal tumors

37. Replacement of two amino acids of 9R-dioxygenase-allene oxide synthase of Aspergillus niger inverts the chirality of the hydroperoxide and the allene oxide.

38. Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis.

Catalog

Books, media, physical & digital resources